Substrate- and pH-specific antifolate transport mediated by organic anion-transporting polypeptide 2B1 (OATP2B1-SLCO2B1)

Molecular Pharmacology

Volumn 81, Issue 2, 2012, Pages 134-142

  Visentin, Michele ^a   Chang, Min Hwang ^b   Romero, Michael F ^b   Zhao, Rongbao ^c   Goldman, I David ^c  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b MAYO GRADUATE SCHOOL   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; BROMSULFOPHTHALEIN; CARBONYL CYANIDE 4 (TRIFLUOROMETHOXY)PHENYLHYDRAZONE; FOLIC ACID; FOLIC ACID ANTAGONIST; METHOTREXATE; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTING POLYPEPTIDE 2B1; PEMETREXED; RALTITREXED; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; GROWTH INHIBITION; HELA CELL; HUMAN; NONHUMAN; OOCYTE; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSPORT KINETICS; XENOPUS LAEVIS;

ANIMALS; BINDING SITES; BIOLOGICAL TRANSPORT; FOLIC ACID ANTAGONISTS; GLUTAMATES; GUANINE; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; INDICATORS AND REAGENTS; OOCYTES; ORGANIC ANION TRANSPORTERS; SUBSTRATE SPECIFICITY; SULFOBROMOPHTHALEIN; XENOPUS LAEVIS;

EID: 84856070846     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.074823     Document Type: Article

References (40)

1. Abe T, Unno M, Onogawa T, Tokui T, Kondo TN, Nakagomi R, Adachi H, Fujiwara K, Okabe M, Suzuki T, et al. (2001) LST-2, a human liver-specific organic aniontransporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology 120:1689-1699. (Pubitemid 32523487)
2. Al Sarakbi W, Mokbel R, Salhab M, Jiang WG, Reed MJ, and Mokbel K (2006) The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer. Anticancer Res 26:4985-4990. (Pubitemid 46032147)
3. Assaraf YG (2007) Molecular basis of antifolate resistance. Cancer Metastasis Rev 26:153-181.
4. Badagnani I, Castro RA, Taylor TR, Brett CM, Huang CC, Stryke D, Kawamoto M, Johns SJ, Ferrin TE, Carlson EJ, et al. (2006) Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants. J Pharmacol Exp Ther 318:521-529. (Pubitemid 44061225)
5. Benz R and McLaughlin S (1983) The molecular mechanism of action of the proton ionophore FCCP (carbonylcyanide p-trifluoromethoxyphenylhydrazone). Biophys J 41:381-398. (Pubitemid 13082077)
6. Diop-Bove NK, Wu J, Zhao R, Locker J, and Goldman ID (2009) Hypermethylation of the human proton-coupled folate transporter (SLC46A1) minimal transcriptional regulatory region in an antifolate-resistant HeLa cell line. Molecular Cancer Therapeutics 8:2424-2431.
7. Goldman ID, Chattopadhyay S, Zhao R, and Moran R (2010) The antifolates: evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of folate analogs. Curr Opin Investig Drugs 11:1409-1423.
8. Grube M, Köck K, Oswald S, Draber K, Meissner K, Eckel L, Böhm M, Felix SB, Vogelgesang S, Jedlitschky G, et al. (2006) Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart. Clin Pharmacol Ther 80:607-620. (Pubitemid 44920223)
9. Hagenbuch B and Meier PJ (2004) Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch 447:653-665. (Pubitemid 38241451)
10. Hayeshi R, Hilgendorf C, Artursson P, Augustijns P, Brodin B, Dehertogh P, Fisher K, Fossati L, Hovenkamp E, Korjamo T, et al. (2008) Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories. Eur J Pharm Sci 35:383-396.
11. Kato K, Shirasaka Y, Kuraoka E, Kikuchi A, Iguchi M, Suzuki H, Shibasaki S, Kurosawa T, and Tamai I (2010) Intestinal absorption mechanism of tebipenem pivoxil, a novel oral carbapenem: involvement of human OATP family in apical membrane transport. Mol Pharm 7:1747-1756.
12. Kobayashi D, Nozawa T, Imai K, Nezu J, Tsuji A, and Tamai I (2003) Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pHdependent transport across intestinal apical membrane. J Pharmacol Exp Ther 306:703-708. (Pubitemid 36886171)
13. Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, and Hagenbuch B (2001) Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 120:525-533. (Pubitemid 32147650)
14. Leuthold S, Hagenbuch B, Mohebbi N, Wagner CA, Meier PJ, and Stieger B (2009) Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. Am J Physiol Cell Physiol 296:C570-C582.
15. Mahadeo KM, Min SH, Diop-Bove N, Kronn D, and Goldman ID (2010) Hereditary folate malabsorption: congenital folate malabsorption, in GeneReviews [Internet] (Pagon RA, Bird TD, Dolan CR, Stephens K eds) University of Washington, Seattle. http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book= gene&part=folate-mal.
16. Matherly LH and Goldman DI (2003) Membrane transport of folates. Vitam Horm 66:403-456.
17. Matherly LH and Hou Z (2008) Structure and function of the reduced folate carrier a paradigm of a major facilitator superfamily mammalian nutrient transporter. Vitam Horm 79:145-184.
18. Mita AC, Sweeney CJ, Baker SD, Goetz A, Hammond LA, Patnaik A, Tolcher AW, Villalona-Calero M, Sandler A, Chaudhuri T, et al. (2006) Phase I and pharmacokinetic study of pemetrexed administered every 3 weeks to advanced cancer patients with normal and impaired renal function. J Clin Oncol 24:552-562. (Pubitemid 46630417)
19. Nakai Y, Inoue K, Abe N, Hatakeyama M, Ohta KY, Otagiri M, Hayashi Y, and Yuasa H (2007) Functional characterization of human proton-coupled folate transporter/ heme carrier protein 1 heterologously expressed in mammalian cells as a folate transporter. J Pharmacol Exp Ther 322:469-476. (Pubitemid 47105788)
20. Nozawa T, Imai K, Nezu J, Tsuji A, and Tamai I (2004) Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human. J Pharmacol Exp Ther 308:438-445. (Pubitemid 38134202)
21. Qiu A, Jansen M, Sakaris A, Min SH, Chattopadhyay S, Tsai E, Sandoval C, Zhao R, Akabas MH, and Goldman ID (2006) Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 127:917-928. (Pubitemid 44792250)
22. Rizwan AN and Burckhardt G (2007) Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles. Pharm Res 24:450-470. (Pubitemid 46295167)
23. Romero MF, Fong P, Berger UV, Hediger MA, and Boron WF (1998) Cloning and functional expression of rNBC, an electrogenic Na(+)-HCO3 - cotransporter from rat kidney. Am J Physiol 274:F425-F432. (Pubitemid 128734064)
24. Sai Y, Kaneko Y, Ito S, Mitsuoka K, Kato Y, Tamai I, Artursson P, and Tsuji A (2006) Predominant contribution of organic anion transporting polypeptide OATP-B (OATP2B1) to apical uptake of estrone-3-sulfate by human intestinal Caco-2 cells. Drug Metab Dispos 34:1423-1431. (Pubitemid 44079886)
25. Sharif KA and Goldman ID (2000) Rapid determination of membrane transport parameters in adherent cells. Biotechniques 28:926-928, 930, 932.
26. Takeda M, Khamdang S, Narikawa S, Kimura H, Hosoyamada M, Cha SH, Sekine T, and Endou H (2002) Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J Pharmacol Exp Ther 302: 666-671. (Pubitemid 34787234)
27. Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M, and Tsuji A (2000) Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun 273:251-260. (Pubitemid 30426895)
28. Tamai I, Nozawa T, Koshida M, Nezu J, Sai Y, and Tsuji A (2001) Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C. Pharm Res 18:1262-1269. (Pubitemid 32846318)
29. Tannock IF and Rotin D (1989) Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 49:4373-4384. (Pubitemid 19208329)
30. Unal ES, Zhao R, Chang MH, Fiser A, Romero MF, and Goldman ID (2009) The functional roles of the His247 and His281 residues in folate and proton translocation mediated by the human proton-coupled folate transporter SLC46A1. J Biol Chem 284:17846-17857.
31. Uwai Y and Iwamoto K (2010) Transport of aminopterin by human organic anion transporters hOAT1 and hOAT3: comparison with methotrexate. Drug Metab Pharmacokinet 25:163-169.
32. Wang L, Cherian C, Desmoulin SK, Polin L, Deng Y, Wu J, Hou Z, White K, Kushner J, Matherly LH, et al. (2010) Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier for cellular entry. J Med Chem 53:1306-1318.
33. Wang Y, Zhao R, and Goldman ID (2004) Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier. Clin Cancer Res 10:6256-6264. (Pubitemid 39287534)
34. Wright JL, Kwon EM, Ostrander EA, Montgomery RB, Lin DW, Vessella R, Stanford JL, and Mostaghel EA (2011) Expression of SLCO transport genes in castrationresistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes. Cancer Epidemiol Biomarkers Prev 20:619-627.
35. Zhao R, Babani S, Gao F, Liu L, and Goldman ID (2000) The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate. Clin Cancer Res 6:3687-3695.
36. Zhao R, Chattopadhyay S, Hanscom M, and Goldman ID (2004) Antifolate resistance in a HeLa cell line associated with impaired transport independent of the reduced folate carrier. Clin Cancer Res 10:8735-8742. (Pubitemid 40053443)
37. Zhao R, Diop-Bove N, Visentin M, and Goldman ID (2011) Mechanisms of membrane transport of folates into cells and across epithelia. Annu Rev Nutr 31:177-201.
38. Zhao R, Gao F, and Goldman ID (2001) Marked suppression of the activity of some, but not all, antifolate compounds by augmentation of folate cofactor pools within tumor cells. Biochem Pharmacol 61:857-865.
39. Zhao R, Matherly LH, and Goldman ID (2009) Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues. Expert Rev Mol Med 11:e4.
40. Zhao R, Qiu A, Tsai E, Jansen M, Akabas MH, and Goldman ID (2008) The protoncoupled folate transporter: impact on pemetrexed transport and on antifolates activities compared with the reduced folate carrier. Mol Pharmacol 74:854-862.